A Great Bargain Stock You Could Consider Is Moleculin Biotech Inc (MBRX)

Moleculin Biotech Inc (NASDAQ:MBRX) has a beta value of 1.56 and has seen 6.72 million shares traded in the recent trading session. The company, currently valued at $10.17M, closed the recent trade at $0.72 per share which meant it lost -$0.12 on the day or -14.32% during that session. The MBRX stock price is -580.56% off its 52-week high price of $4.90 and 44.44% above the 52-week low of $0.40. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.2 million shares traded. The 3-month trading volume is 454.83K shares.

Moleculin Biotech Inc (NASDAQ:MBRX) trade information

Over the past 30 days, the shares of Moleculin Biotech Inc (NASDAQ:MBRX) have changed -30.79%. Short interest in the company has seen 0.98 million shares shorted with days to cover at 2.44.

Moleculin Biotech Inc (MBRX) estimates and forecasts

The company’s shares have lost -74.01% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 26.36% over the past 5 years. Earnings growth for 2025 is a modest 71.73% while over the next 5 years, the company’s earnings are expected to increase by 37.34%.

MBRX Dividends

Moleculin Biotech Inc is expected to release its next earnings report on 2025-May-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Moleculin Biotech Inc (NASDAQ:MBRX)’s Major holders

Insiders own 0.71% of the company shares, while shares held by institutions stand at 10.46% with a share float percentage of 10.54%. Investors are also buoyed by the number of investors in a company, with Moleculin Biotech Inc having a total of 24.0 institutions that hold shares in the company. The top two institutional holders are ARMISTICE CAPITAL, LLC with over 0.16 million shares worth more than $0.55 million. As of 2024-06-30, ARMISTICE CAPITAL, LLC held 6.1339% of shares outstanding.

The other major institutional holder is ATTICUS WEALTH MANAGEMENT, LLC, with the holding of over 3334.0 shares as of 2024-06-30. The firm’s total holdings are worth over $11736.0 and represent 0.1311% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.21% shares in the company for having 30.31 shares of worth $22432.0 while later fund manager owns 18.6 shares of worth $13763.0 as of Mar 31, 2025 , which makes it owner of about 0.13% of company’s outstanding stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.